Skip to main content

Together we are beating cancer

Donate now

Cancer biology

Showing 12 out of 396 results

Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important… Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important…

by Cancer Research UK | In depth | 30 October 2023

30 October 2023

Cancer cells with extrachromosomal DNA (ecDNA)

Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous. Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous.

by Tim Gunn | In depth | 23 October 2023

23 October 2023

CRUK Scotland Institute

Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute

by Amy Warnock | News | 20 September 2023

20 September 2023

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Four bowls containing brown, white, granulated and cubed sugar.
  • Science & Technology
  • Health & Medicine

Sugar and cancer – what you need to know

We take a look at claims that sugar 'feeds' cancer cells and explore the links between the amount of sugar in our diets and obesity. We take a look at claims that sugar 'feeds' cancer cells and explore the links between the amount of sugar in our diets and obesity.

by Cancer Research UK | In depth | 16 August 2023

16 August 2023

An African elephant walking along a dirt track

For World Elephant Day, we're taking a look at why elephants so rarely get cancer. Could the ways they protect themselves help people too? For World Elephant Day, we're taking a look at why elephants so rarely get cancer. Could the ways they protect themselves help people too?

by Tim Gunn | Analysis | 12 August 2023

12 August 2023

Links between retrotransposable elements and cancer have deep roots – George Kassiotis gets into their chequered past and how we might utilise these ancient viral infections   Links between retrotransposable elements and cancer have deep roots – George Kassiotis gets into their chequered past and how we might utilise these ancient viral infections  

by Cancer Research UK | In depth | 11 July 2023

11 July 2023

Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org

by Cancer Research UK | In depth | 19 June 2023

19 June 2023

Bowel cancer cells under the microscope

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

by Jacob Smith | In depth | 25 April 2023

25 April 2023

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

by Phil Prime | In depth | 10 March 2023

10 March 2023

A Cancer Grand Challenges graphic announcing 9 new challenges
  • Health & Medicine
  • Science & Technology

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

A breast cancer cell seen through a special microscope.
  • Science & Technology

Can cancer cells communicate?

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too. Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

by Tim Gunn | Analysis | 28 February 2023

28 February 2023